Skip to main content

GSA CAPITAL PARTNERS LLP

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1362033 LONDON, X0

Position in AMLX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$704,768
+$260,732 QoQ
Shares Held
39,241
+6.8% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#102
of 205 holders
Holding Since
Mar 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $11,914,926 across 21 Drug Manufacturers - Specialty & Generic names. AMLX ranks #7 (5.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 AMLX
Amylyx Pharmaceuticals, Inc.
This page
39,241 $704,768

All Filings in AMLX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $704,768 39,241
2025-12-31 $444,036 36,758
2025-09-30 $708,134 52,107
2025-06-30 $1,093,116 170,533
2025-03-31 $81,720 23,085
2024-12-31 $40,215 10,639
2024-03-31 $226,211 79,652
2023-12-31 $1,945,645 132,177
2023-09-30 $776,984 42,435
2023-06-30 $302,066 14,004
2023-03-31 $237,918 8,109